A Long-term Safety Study of Linerixibat in Cholestatic Pruritus

Study Description

Evaluating the Long-term Safety and Tolerability of Linerixibat in Patients with Cholestatic Pruritus (Itching) due to Primary Biliary Cholangitis

Study Details

Registry ID:

NCT04167358

Conditions:

Cholestasis

Phase:

Phase 3

Target Enrollment:

242 participants

Start Date:

July 14, 2020

Healthy Volunteers:

No

Study Locations (177 sites)

• GSK Investigational Site
  Negrar VeronaItaly, Italy
• GSK Investigational Site
  Reading BerkshireUnited Kingdom, United Kingdom
• GSK Investigational Site
  SevillaSpain, Spain
• GSK Investigational Site
  SevilleSpain, Spain
• GSK Investigational Site
  Valencia, ValenciaSpain, Spain
• GSK Investigational Site
  ValenciaSpain, Spain
• GSK Investigational Site
  PalermoItaly, Italy
• GSK Investigational Site
  MadridSpain, Spain
• GSK Investigational Site
  SalvadorBrazil, Brazil
• GSK Investigational Site
  SalvadorBrazil, Brazil
• GSK Investigational Site
  BarcelonaSpain, Spain
• GSK Investigational Site
  NaplesItaly, Italy
• GSK Investigational Site
  NapoliItaly, Italy
• GSK Investigational Site
  RomaItaly, Italy
• GSK Investigational Site
  MilanItaly, Italy
• GSK Investigational Site
  AthensGreece, Greece
• GSK Investigational Site
  PadovaItaly, Italy
• GSK Investigational Site
  Modena, Emilia-RomagnaItaly, Italy
• GSK Investigational Site
  ModenaItaly, Italy
• GSK Investigational Site
  RozzanoItaly, Italy
• GSK Investigational Site
  RomaItaly, Italy
• GSK Investigational Site
  Milano, LombardiaItaly, Italy
• GSK Investigational Site
  Milano, LombardiaItaly, Italy
• GSK Investigational Site
  MilanoItaly, Italy
• GSK Investigational Site
  MonzaItaly, Italy
• GSK Investigational Site
  Monza (MB), LombardiaItaly, Italy
• GSK Investigational Site
  MonzaItaly, Italy
• GSK Investigational Site
  Monza (MB), LombardiaItaly, Italy
• GSK Investigational Site
  Beer ShevaIsrael, Israel
• GSK Investigational Site
  Negrar Di Valpolicella, VenetoItaly, Italy
• GSK Investigational Site
  LuganoSwitzerland, Switzerland
• GSK Investigational Site
  Padova, VenetoItaly, Italy
• GSK Investigational Site
  RehovotIsrael, Israel
• GSK Investigational Site
  HolonIsrael, Israel
• GSK Investigational Site
  Ramat GanIsrael, Israel
• GSK Investigational Site
  JerusalemIsrael, Israel
• GSK Investigational Site
  HaifaIsrael, Israel
• GSK Investigational Site
  NahariyaIsrael, Israel
• GSK Investigational Site
  SofiaBulgaria, Bulgaria
• GSK Investigational Site
  SofiaBulgaria, Bulgaria
• GSK Investigational Site
  PlovdivBulgaria, Bulgaria
• GSK Investigational Site
  BrasiliaBrazil, Brazil
• GSK Investigational Site
  PlymouthUnited Kingdom, United Kingdom
• GSK Investigational Site
  Lille cedexFrance, France
• GSK Investigational Site
  Lille cedexFrance, France
• GSK Investigational Site
  ErlangenGermany, Germany
• GSK Investigational Site
  Erlangen, BayernGermany, Germany
• GSK Investigational Site
  Erlangen, BavariaGermany, Germany
• GSK Investigational Site
  Southampton, HampshireUnited Kingdom, United Kingdom
• GSK Investigational Site
  SouthamptonUnited Kingdom, United Kingdom
• GSK Investigational Site
  Brasilia, GoiásBrazil, Brazil
• GSK Investigational Site
  BrusselsBelgium, Belgium
• GSK Investigational Site
  GentBelgium, Belgium
• GSK Investigational Site
  RedhillUnited Kingdom, United Kingdom
• GSK Investigational Site
  SurreyUnited Kingdom, United Kingdom
• GSK Investigational Site
  BasingstokeUnited Kingdom, United Kingdom
• GSK Investigational Site
  Basingstoke, HampshireUnited Kingdom, United Kingdom
• GSK Investigational Site
  ReadingUnited Kingdom, United Kingdom
• GSK Investigational Site
  LondonUnited Kingdom, United Kingdom
• GSK Investigational Site
  PlzenCzechia, Czechia
• GSK Investigational Site
  PilsenCzechia, Czechia
• GSK Investigational Site
  Essen, Nordrhein-WestfalenGermany, Germany
• GSK Investigational Site
  Praha 4Czechia, Czechia
• GSK Investigational Site
  Praha 4Czechia, Czechia
• GSK Investigational Site
  PragueCzechia, Czechia
• GSK Investigational Site
  CambridgeUnited Kingdom, United Kingdom
• GSK Investigational Site
  Muenster, Nordrhein-WestfalenGermany, Germany
• GSK Investigational Site
  MuensterGermany, Germany
• GSK Investigational Site
  MünsterGermany, Germany
• GSK Investigational Site
  NottinghamUnited Kingdom, United Kingdom
• GSK Investigational Site
  NottinghamUnited Kingdom, United Kingdom
• GSK Investigational Site
  OstravaCzechia, Czechia
• GSK Investigational Site
  LiverpoolUnited Kingdom, United Kingdom
• GSK Investigational Site
  BotucatuBrazil, Brazil
• GSK Investigational Site
  BotucatuBrazil, Brazil
• GSK Investigational Site
  KatowicePoland, Poland
• GSK Investigational Site
  MyslowicePoland, Poland
• GSK Investigational Site
  MyslowicePoland, Poland
• GSK Investigational Site
  HullUnited Kingdom, United Kingdom
• GSK Investigational Site
  Kingston upon Hull, East Riding Of YorkshireUnited Kingdom, United Kingdom
• GSK Investigational Site
  WroclawPoland, Poland
• GSK Investigational Site
  WroclawPoland, Poland
• GSK Investigational Site
  CzestochowaPoland, Poland
• GSK Investigational Site
  Newcastle Upon TyneUnited Kingdom, United Kingdom
• GSK Investigational Site
  Newcastle Upon Tyne, Tyne And WearUnited Kingdom, United Kingdom
• GSK Investigational Site
  GlasgowUnited Kingdom, United Kingdom
• GSK Investigational Site
  WarszawaPoland, Poland
• GSK Investigational Site
  WarszawaPoland, Poland
• GSK Investigational Site
  Porto AlegreBrazil, Brazil
• GSK Investigational Site
  Porto Alegre, Rio Grande do SulBrazil, Brazil
• GSK Investigational Site
  MoscowRussian Federation, Russian Federation
• GSK Investigational Site
  MoscowRussia, Russia
• GSK Investigational Site
  Ciudad Autonoma De BuenoArgentina, Argentina
• GSK Investigational Site
  Buenos AiresArgentina, Argentina
• GSK Investigational Site
  Capital FederalArgentina, Argentina
• GSK Investigational Site
  Ciudad AutOnoma de Buenos AireArgentina, Argentina
• GSK Investigational Site
  Caba, Buenos AiresArgentina, Argentina
• GSK Investigational Site
  Ciudad Autonoma de Buenos Aires, Buenos AiresArgentina, Argentina
• GSK Investigational Site
  Santa Fe,  santa FeArgentina, Argentina
• GSK Investigational Site
  Santa FeArgentina, Argentina
• GSK Investigational Site
  San NicolasArgentina, Argentina
• GSK Investigational Site
  RosarioArgentina, Argentina
• GSK Investigational Site
  Rosario, Santa FeArgentina, Argentina
• GSK Investigational Site
  SamaraRussia, Russia
• GSK Investigational Site
  SamaraRussian Federation, Russian Federation
• GSK Investigational Site
  Miami, FloridaUnited States, United States
• GSK Investigational Site
  Hialeah, FloridaUnited States, United States
• GSK Investigational Site
  New York, New YorkUnited States, United States
• GSK Investigational Site
  Philadelphia, PennsylvaniaUnited States, United States
• GSK Investigational Site
  Morrisville, North CarolinaUnited States, United States
• GSK Investigational Site
  Durham, North CarolinaUnited States, United States
• GSK Investigational Site
  Toronto, OntarioCanada, Canada
• GSK Investigational Site
  Columbus, OhioUnited States, United States
• GSK Investigational Site
  Detroit, MichiganUnited States, United States
• GSK Investigational Site
  Novi, MichiganUnited States, United States
• GSK Investigational Site
  Houston, TexasUnited States, United States
• GSK Investigational Site
  Ciudad de MExicoMexico, Mexico
• GSK Investigational Site
  Mexico CityMexico, Mexico
• GSK Investigational Site
  Mexico, Ciudad de MéxicoMexico, Mexico
• GSK Investigational Site
  Mexico, Ciudad De MexicoMexico, Mexico
• GSK Investigational Site
  Dallas, TexasUnited States, United States
• GSK Investigational Site
  KemerovoRussian Federation, Russian Federation
• GSK Investigational Site
  KemerovoRussia, Russia
• GSK Investigational Site
  Monterrey, Nuevo LeónMexico, Mexico
• GSK Investigational Site
  MonterreyMexico, Mexico
• GSK Investigational Site
  Omaha, NebraskaUnited States, United States
• GSK Investigational Site
  ChongqingChina, China
• GSK Investigational Site
  Chongqing, SichuanChina, China
• GSK Investigational Site
  Colorado Springs, ColoradoUnited States, United States
• GSK Investigational Site
  Zhanjiang, GuangdongChina, China
• GSK Investigational Site
  Xi'an, ShaanxiChina, China
• GSK Investigational Site
  GuangzhouChina, China
• GSK Investigational Site
  Guangzhou, GuangdongChina, China
• GSK Investigational Site
  ZhengzhouChina, China
• GSK Investigational Site
  NanchangChina, China
• GSK Investigational Site
  Nanchang, JiangxiChina, China
• GSK Investigational Site
  Nanjing, JiangsuChina, China
• GSK Investigational Site
  NanjingChina, China
• GSK Investigational Site
  BeijingChina, China
• GSK Investigational Site
  Los Angeles, CaliforniaUnited States, United States
• GSK Investigational Site
  West Hollywood, CaliforniaUnited States, United States
• GSK Investigational Site
  Culver City, CaliforniaUnited States, United States
• GSK Investigational Site
  TianjinChina, China
• GSK Investigational Site
  ShanghaiChina, China
• GSK Investigational Site
  Edmonton, AlbertaCanada, Canada
• GSK Investigational Site
  Sacramento, CaliforniaUnited States, United States
• GSK Investigational Site
  Davis, CaliforniaUnited States, United States
• GSK Investigational Site
  Seattle, WashingtonUnited States, United States
• GSK Investigational Site
  Changchun, JilinChina, China
• GSK Investigational Site
  ChangchunChina, China
• GSK Investigational Site
  NagasakiJapan, Japan
• GSK Investigational Site
  KagawaJapan, Japan
• GSK Investigational Site
  HiroshimaJapan, Japan
• GSK Investigational Site
  EhimeJapan, Japan
• GSK Investigational Site
  EhimeJapan, Japan
• GSK Investigational Site
  KagawaJapan, Japan
• GSK Investigational Site
  OsakaJapan, Japan
• GSK Investigational Site
  OsakaJapan, Japan
• GSK Investigational Site
  FukuiJapan, Japan
• GSK Investigational Site
  Nara, NaraJapan, Japan
• GSK Investigational Site
  NaraJapan, Japan
• GSK Investigational Site
  FukuiJapan, Japan
• GSK Investigational Site
  FukuiJapan, Japan
• GSK Investigational Site
  ShizuokaJapan, Japan
• GSK Investigational Site
  ShizuokaJapan, Japan
• GSK Investigational Site
  NaganoJapan, Japan
• GSK Investigational Site
  NaganoJapan, Japan
• GSK Investigational Site
  GunmaJapan, Japan
• GSK Investigational Site
  GunmaJapan, Japan
• GSK Investigational Site
  KanagawaJapan, Japan
• GSK Investigational Site
  TokyoJapan, Japan
• GSK Investigational Site
  TokyoJapan, Japan
• GSK Investigational Site
  ChibaJapan, Japan
• GSK Investigational Site
  ChibaJapan, Japan
• GSK Investigational Site
  ChibaJapan, Japan
• GSK Investigational Site
  KanagawaJapan, Japan
• GSK Investigational Site
  HokkaidoJapan, Japan

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →